Johnson & Johnson (JNJ) temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness
- Dow, S&P 500 end with gains up after bumpy week, but Nike drags
- Over $100 Billion Wiped Off: Bitcoin (BTC) Price Falls As China's Central Bank Vows to Ban Cryptocurrency Trading
- Nike (NKE) Stock Falls On a Revenue Miss and Slashed FY Sales Outlook, Analysts Bullish Despite NT Supply Chain Challenges
- Oil hits highest in almost 3 years as supply tightens
- Here's Why Meredith (MDP) Stock Price Soared 18% in After Hours
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Johnson & Johnson (NYSE: JNJ) temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness.
Related vaccine stocks:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walensky Says Will Review J&J (JNJ), Moderna (MRNA) Booster Applications With 'Urgency' - Reuters
- CDC director says boosters needed to protect workers
- Tesla (TSLA) CEO Elon Musk and Grimes break up after three years together - NYP
Create E-mail Alert Related CategoriesFDA, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!